Developing New Medicines For People in Need
At KNOWLEDGESHIFT, LLC, we are forging a new path for people with neurological and psychiatric conditions, beginning with our late-stage investigational candidate, currently in development for epilepsy and depression.
Target validation through human-relevant disease models
Biomarker-driven clinical development
Translational platforms bridging lab research and patient care
Let’s Get Started
Leadership in ion channel science
We are leveraging our heritage in human genetics, deep understanding of ion channel biology, and
expertise in novel chemistries to enable potent, selective ion channel targeting in the central and
peripheral nervous systems.
By combining cutting-edge science, precision medicine, and patient-centered thinking, we aim to
redefine what is possible in brain health. Our approach allows us to identify and develop therapies
with greater specificity and fewer side effects, addressing unmet needs in neurological and
psychiatric disorders.
Through rigorous research, collaboration, and innovation, we are committed to transforming patient
outcomes and advancing the frontier of neuroscience.
Contact Us
Our Core Focus Areas
Neurology
Innovative treatments targeting neurodegenerative and neuroinflammatory conditions, designed to slow disease progression and improve quality of life.
Get Started
Psychiatry
Novel therapeutics addressing unmet needs in mental health, focusing on improved efficacy, safety, and long-term patient outcomes.
Get Started
Orphan Brain Disorders
Precision-driven research programs for rare neurological diseases, where limited treatment options exist and scientific breakthroughs can make life-changing impact.
Get Started
Our Technology Platforms
Neuro-Targeted Drug Delivery
Advanced delivery systems designed to overcome the blood–brain barrier and enhance therapeutic precision.
Biomarker & Imaging Platforms
Leveraging neuroimaging, digital biomarkers, and omics technologies for smarter clinical decisions.
Precision Medicine Engine
Patient stratification tools enabling personalized treatment approaches in CNS disorders.
Common Questions From Our Customers
Our pipeline includes discovery, preclinical, clinical, manufacturing, and technology development projects across life sciences and biotechnology.
Projects are selected based on scientific validity, unmet medical need, development feasibility, and long-term impact.
We advance projects both internally and through strategic collaborations with external partners.
Each project follows structured milestones, data-driven reviews, and strict quality and compliance standards.
